Similar favorable outcomes were observed in Ldlr−/− mice; aneurysm severity, aortic diameter, and associated vessel expansion were all reduced by miR-181b inhibitor treatment (Figure 6F–6H and Online Figure XI). This evidence concerns the gene LDLR and aneurysm.